**Core Concept**
In patients with bilateral renal artery stenosis, it's crucial to select an antihypertensive agent that does not rely on the kidneys for its mechanism of action. This is because these patients are at risk of worsening renal function due to their underlying kidney disease.

**Why the Correct Answer is Right**
The correct answer is an angiotensin-converting enzyme (ACE) inhibitor. ACE inhibitors work by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. However, in patients with bilateral renal artery stenosis, the kidneys are already under significant pressure due to the stenosis. Blocking the conversion of angiotensin I to angiotensin II actually helps to reduce the pressure on the kidneys and can help to preserve renal function. This is because the kidneys are able to maintain their blood flow and glomerular filtration rate (GFR) more effectively.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because diuretics can lead to hypovolemia and decreased renal perfusion, which can worsen renal function in patients with bilateral renal artery stenosis.
**Option B:** This option is incorrect because calcium channel blockers can cause vasoconstriction of the efferent arterioles in the kidneys, leading to a decrease in GFR and potentially worsening renal function in patients with renal artery stenosis.
**Option C:** This option is incorrect because alpha-1 blockers can cause vasodilation, which can lead to a decrease in blood pressure and potentially worsen renal perfusion in patients with bilateral renal artery stenosis.

**Clinical Pearl / High-Yield Fact**
In patients with bilateral renal artery stenosis, it's essential to avoid using antihypertensive agents that can worsen renal function, such as ACE inhibitors (although in this case they are beneficial), diuretics, and alpha-1 blockers. Instead, consider using medications that are renally neutral or vasodilatory, such as calcium channel blockers or alpha-2 agonists.

**Correct Answer:** C.